Updated:
Genome Medical Services
Genome Medical Services is based in San Francisco and was founded in 2016; the profile covers headquarters, registration, AUM band and key contacts for...
Overview
The leading provider of telehealth genetic services. Access expert guidance, accelerate diagnoses and improve rare disease care.
General information
Year founded
2016
Location
Region
North America
Country
United States
City
San Francisco
Corporate office
San Francisco, CA, United States
Principals
Jill Davies
Chief Executive Officer
Mark Sylvester
Chief Financial Officer
Kiley Johnson
Chief Clinical Officer
Sector focus
Frequently asked questions
Who runs investment decisions at Genome Medical Services?
Genome Medical Services is a privately held operational company, not an investment manager. CEO Jill Davies and the leadership team run the business; capital allocation decisions are internal (per the firm's website).
Does Genome Medical Services manage external capital?
No. The company operates as a telehealth service provider, generating revenue through patient consultations and partnerships with health systems, labs, and life sciences organizations (per the firm's website). It does not claim to manage any investment fund.
How does Genome Medical source its clients?
Patients can book a telehealth genetic counseling appointment directly. The company also partners with hospitals, health systems, life sciences companies, and genetic testing laboratories to provide services to their patients (per the firm's website).
What investment stages does Genome Medical Services typically target?
None. Genome Medical is a healthcare services business, not an investment firm. It does not make venture or growth-stage investments.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: